Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from AOTI, Inc. ( (GB:AOTI) ) is now available.
AOTI, Inc. announced the conclusion of its ‘distribution compliance period’ under Regulation S of the US Securities Act, allowing the removal of the ‘REG S’ designation from its securities. This development marks a significant step for the company, potentially enhancing its market positioning and accessibility for investors, as it no longer restricts the resale of securities for certain US Persons.
More about AOTI, Inc.
AOTI, Inc. is a medical technology company founded in 2006, with operations in Oceanside, California, and Galway, Ireland. The company specializes in innovative solutions for severe and chronic wound healing, particularly focusing on reducing healthcare costs and improving patient quality of life. AOTI’s patented non-invasive Topical Wound Oxygen (TWO2®) therapy has shown significant efficacy in reducing the recurrence of Diabetic Foot Ulcers, hospitalizations, and amputations, with regulatory approvals across multiple countries.
Average Trading Volume: 45,045
Technical Sentiment Signal: Sell
Current Market Cap: £101M
For detailed information about AOTI stock, go to TipRanks’ Stock Analysis page.